Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review

Yora Mostmans1,2, Katleen De Smedt3, Bertrand Richert2

  • 1Department of Immunology-Allergology, CHU Brugmann, Université Libre de Bruxelles, Bruxelles, Belgium.

Allergy
|March 26, 2021
PubMed

Insights

This review identifies key biomarkers indicating endothelial cell (EC) dysfunction in chronic urticaria (CU). Findings highlight specific markers in skin and serum, confirming vascular involvement in CU pathogenesis.

Area of Science:

  • Immunology
  • Dermatology
  • Vascular Biology

Background:

  • Chronic urticaria (CU) is a mast cell-driven inflammatory condition.
  • Endothelial cells (ECs) play a significant role in CU pathogenesis.
  • Systematic review of EC dysfunction markers in CU is lacking.

Purpose of the Study:

  • To systematically review and categorize published markers of endothelial cell (dys)function in chronic urticaria.
  • To identify reliable biomarkers for EC dysfunction in CU skin and serum.
  • To consolidate evidence for vascular involvement in CU.

Main Methods:

  • Comprehensive literature search of PubMed, Cochrane Library, Web of Science, and SCOPUS.
  • Used Mesh terms: CU AND pathogenesis AND (vasculopathy OR microangiopathy OR ECs OR marker).
  • Selected 79 articles and categorized identified biomarkers based on EC function.

Main Results:

  • Upregulated biomarkers in CU skin include adhesion molecules, tissue factor (TF), and P-selectin.
  • Reliable serum biomarkers in CU patients are F1+2 (coagulation), D-dimers (fibrinolysis), and MMP-9 (vascular permeability).
  • Emerging biomarkers include endostatin, heat shock proteins, cleaved high molecular weight kininogen, and adipokines.

Conclusions:

  • This review confirms EC dysfunction in CU, affecting cell survival, vascular structure, and coagulation/fibrinolysis.
  • Identified biomarkers provide insights into CU pathophysiology.
  • Evidence supports significant vascular involvement in chronic urticaria.